Terms ending in 2039
Every in-force patent on Ono Pharmaceutical Co., Ltd.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,091,550 | Bispecific Antibody In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 12,091,461 | Bispecific Antibody In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,198,672 | Compounds Having S1P5 Receptor Agonistic Activity In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 12,049,445 | Compounds Having S1P5 Receptor Agonistic Activity In force · Low confidence | Ono Pharmaceutical Co., Ltd. | In force | Low confidence | |
| US 11,572,393 | HMGN Partial Peptide and Cancer Therapy Using the Same In force · High confidence | Tokyo University of Science Foundation | In force | High confidence | |
| US 11,919,932 | HMGN Partial Peptide and Cancer Therapy Using the Same In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,261,154 | Benzene Derivative In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 12,258,308 | Benzene Derivative In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,130,773 | Sting Agonistic Compound In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,919,917 | Sting Agonistic Compound In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| 1 more term end in 2039 · Pro | |||||
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11.
10 of these are in force and held by Ono Pharmaceutical Co., Ltd..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.